U.S., Jan. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07361250) titled 'Subthalamic Nucleus (STN) Targeted Transcranial Temporal Interference Stimulation (TIS) Treats Parkinson's Disease' on Dec. 14, 2025.
Brief Summary: This is a single-center, prospective, double-blind, randomized controlled trial to evaluate the efficacy and safety of transcranial temporal interference stimulation targeting the subthalamic nucleus in patients with Parkinson's disease. It plans to enroll 20 eligible participants who will be randomly assigned in a 1:1 ratio to either the active TIS stimulation group or the sham stimulation group.
Study Start Date: Jan. 20
Study Type: INTERVENTIONAL
Condition:
Parkinson Disease
Int...